RENIN

RENIN 詳細

英語名Renin市販薬剤の数4
治験薬の数3ターゲットの別称REN,Renin,Angiotensinogenase,Angiotensin-Forming Enzyme,Renin Precursor, Renal,HNFJ2,EC:3.4.23.15,EC 3.4.23.15,EC 3.4.23
研究&開発段階Approved
英語名Renin
ターゲットの別称REN,Renin,Angiotensinogenase,Angiotensin-Forming Enzyme,Renin Precursor, Renal,HNFJ2,EC:3.4.23.15,EC 3.4.23.15,EC 3.4.23
市販薬剤の数4
治験薬の数3
研究&開発段階Approved

RENIN 製品リスト

  • 属性

    Protein (2)

  • 製品ライブラリ

    オンライン (2)

  • Human (1)Mouse (1)

  • タグ

    His Tag (2)

  • マーカー

    Unconjugated (2)

製品番号発現システム製品説明タンパク質の構造純度特性
REN-H5221
Human
HEK293
Human RENIN Protein, His Tag
REN-M5222
Mouse
HEK293
Mouse RENIN Protein, His Tag
総数量2
  • 1

RENINバックグランド

Renin is also known as REN and angiotensinogenase, is a circulating enzyme that participates in the body's renin-angiotensin system (RAS), and plays an essential role in the elevation of arterial blood pressure and increased sodium retention by the kidney. Renin activates the renin-angiotensin system by cleaving angiotensinogen, produced by the liver, to yield angiotensin I, which is further converted into angiotensin II by ACE, the angiotensin-converting enzyme primarily within the capillaries of the lungs. Renin is secreted from kidney cells, which are activated via signaling from the macula densa, which responds to the rate of fluid flow through the distal tubule, by decreases in renal perfusion pressure (through stretch receptors in the vascular wall), and by sympathetic nervous stimulation, mainly through beta-1 receptor activation. Renin can bind to ATP6AP2, which results in a fourfold increase in the conversion of angiotensinogen to angiotensin I over that shown by soluble renin. In addition, renin binding results in phosphorylation of serine and tyrosine residues of ATP6AP2. The level of renin mRNA appears to be modulated by the binding of HADHB, HuR and CP1 to a regulatory region in the 3' UTR. An over-active renin-angiotension system leads to vasoconstriction and retention of sodium and water. These effects lead to hypertension. Therefore, renin inhibitors can be used for the treatment of hypertension.

RENIN分子の別称

REN,FLJ10761,Renin,angiotensinogenase

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
MT-2765MT-2765Phase 3 ClinicalMitsubishi Tanabe Pharma CorpHypertension
詳細
SP-20104 (Sarfez Pharmaceuticals)SP-20104Phase 2 Clinical1 A Pharma GmbhGlomerulosclerosis, Focal Segmental
詳細
Imarikiren hydrochlorideTAK-272; SCO-272Phase 2 ClinicalTakeda Pharmaceutical Co LtdDiabetic Nephropathies; Hepatic Insufficiency; Hypertension; Renal Insufficiency
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Aliskiren Hemifumarate/Amlodipine Besilate/HydrochlorothiazideApprovedNovartis Pharma AgRasitrio, AmturnideUnited StatesHypertensionnull2010-12-21Essential Hypertension; Hypertension
詳細
Sitokiren MalateMT-2765; MT2765; I-001; SPH-3127; I001-A; I001-BApprovedMitsubishi Tanabe Pharma, Shanghai Pharmaceuticals Holding Co Ltd信妥安Mainland ChinaEssential HypertensionShanghai Sine Pharmaceutical Laboratories Co Ltd2025-12-03Colitis, Ulcerative; Diabetic Nephropathies; Essential Hypertension; Hypertension; Kidney Diseases; Psoriasis
詳細
Aliskiren HemifumarateCGP-60536; SPP-100; SPP-100B; SPP-100A; CGP-60536BApprovedNovartis Pharma AgSprimeo, Enviage, Tekturna, Riprazo, 锐思力, RasilezUnited StatesHypertensionNoden Pharma Dac2007-03-05Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic macular oedema; Diabetic Nephropathies; Essential Hypertension; Glomerulonephritis, IGA; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Myocardial Infarction; Myocardial Ischemia; Overweight
詳細
AliskirenApprovedMainland ChinaEssential HypertensionNovartis Pharma Ag2010-03-26Essential Hypertension
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8